Latest filings (excl ownership)
15-12B
Securities registration termination
17 May 21
S-8 POS
Registration of securities for employees (post-effective amendment)
5 May 21
S-8 POS
Registration of securities for employees (post-effective amendment)
5 May 21
S-8 POS
Registration of securities for employees (post-effective amendment)
5 May 21
POSASR
Automatic shelf registration (post-effective amendment)
5 May 21
8-K
Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc
5 May 21
25-NSE
Exchange delisting
5 May 21
10-Q
2021 Q1
Quarterly report
3 May 21
10-K/A
2020 FY
Annual report (amended)
30 Apr 21
8-K
GW Pharmaceuticals Shareholders Approve Acquisition by Jazz Pharmaceuticals
23 Apr 21
DEFA14A
Additional proxy soliciting materials
20 Apr 21
8-K
Other Events
20 Apr 21
DFAN14A
Additional proxy materials by non-management
20 Apr 21
DEFA14A
Additional proxy soliciting materials
14 Apr 21
8-K
Other Events
14 Apr 21
DEFA14A
Additional proxy soliciting materials
25 Mar 21
DEFA14A
Additional proxy soliciting materials
24 Mar 21
DFAN14A
Additional proxy materials by non-management
23 Mar 21
DEFA14A
Additional proxy soliciting materials
23 Mar 21
8-K
Other Events
23 Mar 21
DEFA14A
Additional proxy soliciting materials
15 Mar 21
DEFM14A
Proxy related to merger
15 Mar 21
PREM14A
Preliminary proxy related to merger
5 Mar 21
10-K
2020 FY
Annual report
26 Feb 21
DFAN14A
Additional proxy materials by non-management
26 Feb 21
DFAN14A
Additional proxy materials by non-management
24 Feb 21
DFAN14A
Additional proxy materials by non-management
24 Feb 21
DFAN14A
Additional proxy materials by non-management
23 Feb 21
8-K
GW Pharmaceuticals plc Reports Fourth Quarter and Year-End 2020 Financial Results and Operational Progress
16 Feb 21
DFAN14A
Additional proxy materials by non-management
8 Feb 21
DFAN14A
Additional proxy materials by non-management
8 Feb 21
DEFA14A
Additional proxy soliciting materials
5 Feb 21
DFAN14A
Additional proxy materials by non-management
5 Feb 21
DEFA14A
Additional proxy soliciting materials
4 Feb 21
DFAN14A
Additional proxy materials by non-management
4 Feb 21
DFAN14A
Additional proxy materials by non-management
4 Feb 21
DEFA14A
Additional proxy soliciting materials
4 Feb 21
DEFA14A
Additional proxy soliciting materials
4 Feb 21
DFAN14A
Additional proxy materials by non-management
4 Feb 21
DFAN14A
Additional proxy materials by non-management
4 Feb 21
Latest ownership filings
SC 13G/A
Capital World Investors
11 Feb 22
4
Christopher J. Tovey
7 May 21
4
Darren S Cline
7 May 21
4
DAVID W GRYSKA
7 May 21
4
Douglas B. Snyder
7 May 21
4
Justin D. Gover
7 May 21
4
James Noble
7 May 21
4
CATHERINE J MACKEY
7 May 21
4
Volker Knappertz
7 May 21
4
GEOFFREY W DR GUY
7 May 21
4
Scott M. Giacobello
7 May 21
4
Alicia Secor
7 May 21
4
Cabot Brown
7 May 21
4
William A. Waldegrave
7 May 21
4
Douglas B. Snyder
8 Apr 21
4
Volker Knappertz
30 Mar 21
4
Cabot Brown
22 Mar 21
4
Justin D. Gover
22 Mar 21
SC 13G/A
Capital Research Global Investors
10 Mar 21
4
Scott M. Giacobello
4 Mar 21
4
Darren S Cline
4 Mar 21
4
Justin D. Gover
4 Mar 21
4
Douglas B. Snyder
4 Mar 21
4
CATHERINE J MACKEY
2 Mar 21
4
Alicia Secor
2 Mar 21
4
Cabot Brown
2 Mar 21
4
Douglas B. Snyder
2 Mar 21
4
Volker Knappertz
2 Mar 21
4
Justin D. Gover
2 Mar 21
4
Scott M. Giacobello
2 Mar 21
4
Alicia Secor
25 Feb 21
4
Volker Knappertz
24 Feb 21
4
CATHERINE J MACKEY
24 Feb 21
4
DAVID W GRYSKA
24 Feb 21
4
Darren S Cline
24 Feb 21
4
Douglas B. Snyder
24 Feb 21
4
Justin D. Gover
24 Feb 21
4
Cabot Brown
24 Feb 21
4
William A. Waldegrave
24 Feb 21
4
GEOFFREY W DR GUY
24 Feb 21